Series A - Amylyx Pharmaceuticals
Investment Firm
Overview
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
Announced Date
Aug 22, 2016
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
3
Round Details and Background
Amylyx Pharmaceuticals raised $5000000 on 2016-08-22 in Series A
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
Company Funding History
8
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 06, 2022 |  Post-IPO Equity - Amylyx Pharmaceuticals | - | 246.3M | |
| Aug 22, 2016 | Series A - Amylyx Pharmaceuticals | 3 | - | 5.0M |
| Jul 20, 2016 | Seed Round - Amylyx Pharmaceuticals | 2 | - | 3.0M |
| Nov 17, 2015 | Seed Round - Amylyx Pharmaceuticals | - | 1.4M |
Recent Activity
There is no recent news or activity for this profile.